干扰素-玛释放试验与结核素皮肤试验用于活性结核病诊断:系统性审查和诊断性元分析
Muhammad Abubaker Tobaiqi1, Musleh Naser Alshamrani2, Shyamkumar Sriram3
1Department of Family and Community Medicine and Medical Education, College of Medicine, Taibah University, Madinah 42353, Saudi Arabia.
Diagnostics (Basel, Switzerland)
|September 27, 2025
概括
干扰素-释放试验 (IGRA) 的准确性比结核素皮肤试验 (TST) 更高,用于诊断活跃结核病 (TB). 伊格拉 (IGRA) 是一个
科学领域:
- 传染性疾病 传染性疾病
- 诊断医学 诊断医学
- 公共卫生 公共卫生
背景情况:
- 全球结核病 (TB) 消除取决于有效的诊断和治疗.
- 干扰素释测试 (IGRA) 为诊断Mycobacterium结核病感染提供了传统结核素皮肤测试 (TST) 的替代方案.
- 关于用IGRA取代TST作为标准诊断工具的存在争议.
研究的目的:
- 为了比较IGRAs与TST的诊断准确性,用于检测活跃的结核病例.
- 评估两种诊断方法对结核病培养的敏感性和特异性.
主要方法:
- 来自四个数据库的研究的系统审查.
- 使用OpenMeta Analyst软件进行诊断元分析.
- 计算聚合灵敏度 (SN) 和特异性 (SP) 以95%的置信区间 (CI),按各种因素分层.
主要成果:
- 与TST (SN: 72.4%,SP: 79.3%) 相比,IGRA显示出更高的诊断准确性 (SN: 78.9%,SP: 85.7%).
- 在成人和儿童群体中,IGRA的表现优于TST.
- 免疫受损个体的表现各不相同,TST显示低SN但高SP,而IGRA具有更高的SN但更低的SP.
结论:
- 对于活跃的结核病检测,IGRA在大多数子组中始终表现出比TST更高的诊断准确性.
- IGRA具有作为活跃结核病诊断的卓越工具的潜力.
更多相关视频
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
12.7K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.9K
相关概念视频
01:26Pulmonary Tuberculosis IV
478
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
478
01:31Pulmonary Tuberculosis III
937
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
937
01:28Pulmonary Tuberculosis V
540
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
01:28Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K